Loading organizations...
§ Private Profile · Kunshan, Anhui, China
Biopharmaceutical company focused on innovative cancer treatments.
Zelgen has raised $62.0M across 1 funding round.
Zelgen has raised $62.0M in total across 1 funding round.
Zelgen has raised $62.0M across 1 funding round. Most recently, it raised $62.0M Series B in January 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 15, 2018 | $62M Series B | Minsheng Insurance, Share Ventures, Shenzhen Capital Group | Aurora Investment, China Youth Guorong | Announced |
Zelgen has raised $62.0M in total across 1 funding round.
Zelgen's investors include Minsheng Insurance, Share Ventures, Shenzhen Capital Group, Aurora Investment, China Youth Guorong.